• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23808 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     NIHR Health Technology Assessment programme A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO Trial
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Percutaneous vertebroplasty in the treatment of osteoporotic vertebral fractures]
2009     Penn Medicine Center for Evidence-based Practice (CEP) Post operative use of COX-2 inhibitors in bone surgery
2009     NIHR Horizon Scanning Centre (NIHR HSC) Cediranib (Recentin) for recurrent glioblastoma multiforme - second or third line
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening of average risk individuals: a systematic review of accuracy and compliance
2009     Committee for New Health Technology Assessment (CNHTA) [PMP22 exon deletion/duplication test [MLPA]]
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of malignant lymphoma]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care HIV testing: a review of the clinical and cost-effectiveness and diagnostic accuracy
2009     NIHR Health Technology Assessment programme Varenicline in the management of smoking cessation: a single technology appraisal
2009     NIHR Health Technology Assessment programme Randomised controlled trial of the use of the three dressing preparations in the management of chronic ulceration of the foot in diabetes
2009     Penn Medicine Center for Evidence-based Practice (CEP) High frequency jet ventilation in cardiac ablation procedures
2009     NIHR Horizon Scanning Centre (NIHR HSC) Cediranib (Recentin) with XELOX or FOLFOX for advanced metastatic colorectal cancer - first line
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography: a review of the risk of cancer associated with radiation exposure
2009     Committee for New Health Technology Assessment (CNHTA) [PMS2 gene mutation analysis(sequencing)]
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Alteplase (rt-PA) in the cerebral vascular ischemic accident]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Acupuncture for managing chronic shoulder and lower back pain: a review of optimal frequency
2009     NIHR Health Technology Assessment programme Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal
2009     NIHR Health Technology Assessment programme Randomised controlled trial to determine the clinical and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care. The THREAD (THREshold for AntiDepressant response) study
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Perioperative strategy in colonic surgery; laparoscopy and/or fast track multimodal management versus standard care]
2009     NIHR Health Technology Assessment programme Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis
2009     NIHR Health Technology Assessment programme Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional hemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation
2009     Penn Medicine Center for Evidence-based Practice (CEP) Observation units
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ataluren for nonsense mutation dystrophinopathy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumors of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost effectiveness
2009     Committee for New Health Technology Assessment (CNHTA) [PROS1 exon deletion/duplication test[MLPA]]
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of breast cancer]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous administration of proton pump inhibitors in palliative care patients: a review of clinical effectiveness and guidelines
2009     NIHR Health Technology Assessment programme Rituximab for the treatment of rheumatoid arthritis
2009     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Implantable device for the treatment of drug-resistant hypertension
2009     Health Sciences Institute in Aragon (IACS) Diabetes complications. Diabetic nephropathy
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Pregnancy-induced hypertension and pre-eclampsia after 36 weeks: induction of labour versus expectant monitoring. A comparison of maternal and neonatal outcome, maternal quality of life and costs?]
2009     Penn Medicine Center for Evidence-based Practice (CEP) Mechanical prophylaxis for venous thromboembolism after ambulatory surgery
2009     NIHR Horizon Scanning Centre (NIHR HSC) Albinterferon alfa-2b (Joulferon) for hepatitis C with compensated liver disease
2009     Committee for New Health Technology Assessment (CNHTA) [SERPINC1 exon deletion/duplication test [MLPA]]
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of colon and rectal cancer]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous lidocaine in community care: a review of the guidelines and patient safety
2009     NIHR Health Technology Assessment programme Omalizumab for the treatment of severe persistent allergic asthma
2009     Penn Medicine Center for Evidence-based Practice (CEP) Management of diabetic ketoacidosis in wards/intermediate care units
2009     NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for locally advanced or metastatic non-small cell lung cancer - second line
2009     Committee for New Health Technology Assessment (CNHTA) [Heparin-Platelet Factor 4(PF4) antibody test]
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of polyglycolic polymerized matrix artery graft]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Managing crohn's disease in adults: a summary of the guidelines
2009     NIHR Health Technology Assessment programme Adalimumab for the treatment of psoriasis
2009     Health Sciences Institute in Aragon (IACS) Diabetes complications. Diabetic retinopathy
2009     NIHR Health Technology Assessment programme The effects of biofeedback for the treatment of essential hypertension: a systematic review
2009     Penn Medicine Center for Evidence-based Practice (CEP) Isosmolar iodixanol versus low-osmolar contrast agents for imaging
2009     NIHR Horizon Scanning Centre (NIHR HSC) AEGR-733 (Lomitapide) for hypercholesterolaemia
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Dabigatran or Rivaroxaban versus other anticoagulants for thromboprophylaxis after major orthopedic surgery: systematic review of comparative clinical-effectiveness and safety
2009     Committee for New Health Technology Assessment (CNHTA) [SLC12A3 gene, mutation [sequencing]]
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of head and neck cancers]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Gliclazide MR versus glyburide for management of type 2 diabetes: a review of the clinical effectiveness and safety
2009     NIHR Health Technology Assessment programme Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal
2009     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Follow-up in gynaecological cancer patients - a health technology assessment]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Primary maximal necrosectomy versus a minimally invasive step up approach in patients with necrotising pancreatitis; PANTER, a randomised controlled trial. Dutch Acute Pancreatitis Study Group]
2009     NIHR Health Technology Assessment programme The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis
2009     HAYES, Inc. Phototherapy for acne vulgaris
2009     NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for metastatic colorectal cancer - second line
2009     Andalusian Health Technology Assessment Area (AETSA) [Development of criteria, complexity indicators and management strategies on frailty]
2009     Committee for New Health Technology Assessment (CNHTA) [SMN1 gene, mutation[sequencing]]
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of radiofrequency ablation in the surgical treatment of atrial fibrillation]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sharp and round optic edges of intraocular lenses: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer
2009     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) National strategi for medicinsk teknologivurdering - Bedre grundlag for planlægning og prioritering for sundhedsområdet
2009     HAYES, Inc. Positron emission tomography (PET) for diagnosing and staging lung cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Cabazitaxel (XRP-6258) for hormone refractory, metastatic prostate cancer - second line after docetaxel
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Dialectical Behavior Therapy in adolescents for suicide prevention: Systematic review of clinical-effectiveness
2009     Committee for New Health Technology Assessment (CNHTA) [Percutaneous tracheostomy dilator]
2009     Blue Cross Blue Shield Association (BCBS) Special report: vaccines for the treatment of prostate cancer
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of basal action recombinant insulin, analogous to human insulin, (glargine and determir) for treating type 1 diabetes mellitus]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Hypertonic saline nebules for patients with cystic fibrosis and bronchioectasis: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal
2009     NIHR Health Technology Assessment programme VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Randomized trial of timing of delivery in early preterm fetal growth restriction based on early and late fetal Doppler venous changes versus cardiotocography. Acronym TRUFFLE = Trial of Umbilical and Fetal Flow in Europe]
2009     NIHR Health Technology Assessment programme Use of classical and novel biomarkers as prognostic risk factors for prostate cancer: a systematic review
2009     HAYES, Inc. Positron emission tomography (PET) for treatment planning of lung cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Neurology monitoring (Entropy) for depth of anaesthesia
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada
2009     Committee for New Health Technology Assessment (CNHTA) [Intra-abdominal pressure monitoring with abviser]
2009     Blue Cross Blue Shield Association (BCBS) Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of paliperidone for treating schizophrenia]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Docetaxel for the adjuvant treatment of early breast cancer
2009     NIHR Health Technology Assessment programme Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
2009     NIHR Horizon Scanning Centre (NIHR HSC) Eplivanserin for chronic insomnia characterised by difficulties with sleep maintenance
2009     Health Intervention and Technology Assessment Program (HITAP) The Thai population based preference scores for EQ5D health states
2009     Committee for New Health Technology Assessment (CNHTA) [Magnetic remote controlled catheter navigation technique]
2009     Blue Cross Blue Shield Association (BCBS) Cardiac resynchronization therapy for mild congestive heart failure
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of rituximabe in treating B-cell non-hodgkin's lymphoma, low-grade CD 20]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral endotracheal tube placement in neonates, pediatric, and adult patients: a review of the guidelines
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [The cost-effectiveness of NT-pro-brain natriuretic peptide (NT-proBNP) guided therapy of chronic heart failure]
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Platelet rich plasma for the treatment of tendinosis
2009     NIHR Horizon Scanning Centre (NIHR HSC) Eribulin for locally advanced or metastatic breast cancer - third line; monotherapy
2009     Health Intervention and Technology Assessment Program (HITAP) Assessing the implication of Thailand's government use licenses issued in 2006-2008
2009     Committee for New Health Technology Assessment (CNHTA) [VKORCI genotyping[Real-time PCR-melting point analysis]]
2009     Blue Cross Blue Shield Association (BCBS) Accelerated radiotherapy after breast-conserving surgery for early stage breast cancer
2009     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of the artery protection system Embol-X]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of hydromyelia in adults: a review of clinical effectiveness and guidelines
2009     Norwegian Knowledge Centre for the Health Services (NOKC) [Effects of psychotherapy for adults with depression]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [The cost-effectiveness of ST analysis of the fetal electrocardiogram as compared to fetal blood sampling for intrapartum fetal monitoring: a randomised controlled trial]
2009     NIHR Health Technology Assessment programme Continuous positive airways pressure (CPAP) for the treatment of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)